PMX Inc.
PMX is a medical technology company that delivers personalized health insights using a breakthrough AI-assisted imaging platform. Founded in April 2021, PMX has developed an automated multi-modality imaging platform, called MediOMX, to build end-to-end applications that measure the vital organs and tissues of the body for universal care and wellness. PMX product pipeline is designed such that it does not distract the existing radiological workflow, instead, it improves the current one by connecting the chain of image acquisition, processing, and reporting system. Our quick, accurate, and cost-effective solutions are highly beneficial to all stakeholders in the imaging ecosystem including patients, referring clinicians, radiologists, and administration. Using this end-to-end platform, we have built 3 main use cases as follows: - 15 minutes dementia screening using brain MRI; - Full body MRI screening for assessing an athlete's body and performing injury risk analysis; - Chest CT screening for various lung diseases particularly infiltrating pneumonia such as COVID-19
PMX Inc.
PMX is a medical technology company that delivers personalized health insights using a breakthrough AI-assisted imaging platform. Founded in April 2021, PMX has developed an automated multi-modality imaging platform, called MediOMX, to build end-to-end applications that measure the vital organs and tissues of the body for universal care and wellness. PMX product pipeline is designed such that it does not distract the existing radiological workflow, instead, it improves the current one by connecting the chain of image acquisition, processing, and reporting system. Our quick, accurate, and cost-effective solutions are highly beneficial to all stakeholders in the imaging ecosystem including patients, referring clinicians, radiologists, and administration. Using this end-to-end platform, we have built 3 main use cases as follows: - 15 minutes dementia screening using brain MRI; - Full body MRI screening for assessing an athlete's body and performing injury risk analysis; - Chest CT screening for various lung diseases particularly infiltrating pneumonia such as COVID-19
TL;DR
Headquarters: Palatine, Illinois, United States
Product: MediOMX — automated multi-modality AI-assisted imaging platform
Founded: April 2021
Recent funding stage: Series A (Dec 24, 2021)
Employee count: 159
Company Overview
Problem Domain
Medical imaging automation, clinical screening and wellness assessment using AI
Founded
2021
Industry
Medical technology
Funding Track Record
100000.00
Investor Signal
“Company lists six investors including BNK Venture Capital, Korea Alternative Investment Asset Management, and Intervalue Partners.”